Phase II Trial of CG8123, an Autologous Cancer Vaccine (GVAX), in Patients With Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC).
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2012
At a glance
- Drugs Tumour cell vaccine-GVAX (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 23 Jul 2012 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
- 08 Jun 2011 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 13 Oct 2005 New trial record.